TY  - JOUR
T1  - Mikrobiyotaya Etki Eden Etmenler
TT  - The Factors Affecting Microbiota
AU  - Tatar, Tuğba
AU  - Emir, Aleyna
PY  - 2023
DA  - December
DO  - 10.59778/sbfdergisi.1337716
JF  - Kastamonu Üniversitesi Sağlık Bilimleri Fakültesi Dergisi
JO  - KUSBFD
PB  - Kastamonu Üniversitesi
WT  - DergiPark
SN  - 2980-0005
SP  - 166
EP  - 175
VL  - 2
IS  - 3
LA  - tr
AB  - Mikrobiyota birçok mikroorganizmayı içerisinde barındıran, immünolojik, hormonal ve metabolik açıdan önemi son dönemlerde daha fazla anlaşılan bir yapıdır. Mikrobiyota immünolojik sisteminin güçlendirilmesi, bazı vitaminlerin sentezlenmesi, sindirim ve emilim faaliyetlerinin gerçekleştirilmesi, bağırsak bütünlüğünün korunması, inflamasyonun önlenmesi, nörolojik faaliyetler, sağlıklı vücut ağırlığına kavuşulması gibi çok farklı metabolik işlevlerin gerçekleşmesinde önemli roller üstlenmektedir. Mikrobiyotanın oluşumunu ve gelişimini etkileyen birçok faktör bulunmaktadır. Bu derlemede bu faktörlerden bazılarına değinilmiştir. Probiyotikler ve prebiyotikler faydalı mikrobiyal yükü artırarak mikrobiyotanın düzenlenmesinde fayda sağlar. Genel itibariyle bitkisel kaynaklı besinlerde bulunan polifenoller mikrobiyotayı olumlu yönde etkilemektedir. Mikrobiyota ile polifenoller arasında karşılıklı bir ilişki bulunmaktadır. Mikrobiyota polifenollerin biyoyararlılığını ve biyolojik aktivitesini artırabilirken, polifenollerin de mikrobiyotanın faydalı mikrobiyal çeşitliliğini artırabildiği gösterilmiştir. Mikrobiyota ilaçların emilim, metabolizma, toksisite gibi mekanizmalarını etkileyerek kimyasal değişikliklere uğraması ve metabolize edilmesinde önemli roller üstlenmektedir. Bununla birlikte antibiyotikler başta olmak üzere bazı ilaçlar mikrobiyom bileşimi, metabolizması ve konak etkileşimini değiştirebilmektedir. Emülgatörler veya yapay tatlandırıcılar gibi gıda katkı maddeleri mikrobiyota bileşimini etkileyebilmektedir. Emülgatörlerin mikrobiyota disbiyozu ile ilişkili hastalıkları artırdığı gösterilmiştir. Yapay tatlandırıcıların da mikrobiyota üzerine olumsuz etkileri nedeniyle obezite ve glukoz intoleransı eğilimini artırdığı düşünülmektedir. Mikrobiyota leptin ekspresyonu üzerinde etkili olabilmekte ve vücut ağırlığı kazanımında rol oynayabilmektedir. Sonuç olarak mikrobiyotanın bileşimi ve mikrobiyal yükün yoğunluğu insan sağlığı üzerinde birçok olumlu veya olumsuz etki oluşturabilmektedir. Önemi gün geçtikçe daha fazla anlaşılan mikrobiyotaya etki eden etmenlerin daha fazla anlaşılması ve altta yatan mekanizmaların bilinmesi sağlıklı bir mikrobiyota oluşumu için önem arz etmektedir. Sağlıklı bir mikrobiyota oluşturmak obezite, inflamasyon, diyabet gibi birçok hastalığın önlenmesinde ve bireylerin genel sağlığının iyileşmesinde aktif olarak rol oynamaktadır.
KW  - Mikrobiyota
KW  - Pre-probiyotikler
KW  - Polifenoller
KW  - Gıda katkı maddeleri
KW  - Leptin
N2  - Microbiota is a structure that contains many microorganisms, and its importance in immunological, hormonal, and metabolic terms has been understood more recently. Microbiota plays an essential role in many different metabolic functions, such as strengthening the immunological system, synthesizing some vitamins, digestive and absorption activities, protecting the integrity of the intestine, preventing inflammation, neurological activities, and attaining healthy body weight. Many factors affect the formation and development of microbiota. In this review, some of these factors are mentioned. Probiotics and prebiotics increase the beneficial microbial load and contribute to regulating the microbiota. In general, polyphenols found in plant-based foods positively affect the microbiota. There is a reciprocal relationship between microbiota and polyphenols. It has been shown that while the microbiota can increase the bioavailability and biological activity of polyphenols, polyphenols can increase the beneficial microbial diversity of the microbiota. Microbiota plays an important role in drug chemical changes and metabolism by influencing mechanisms such as absorption, metabolism, and toxicity. However, some medications, especially antibiotics, can change the microbiome composition, metabolism, and host interaction. Food additives such as emulsifiers or artificial sweeteners can affect the composition of the microbiota. Emulsifiers have been shown to increase diseases associated with microbiota dysbiosis. Artificial sweeteners are also thought to increase the tendency of obesity and glucose intolerance due to their harmful effects on the microbiota. Microbiota can affect leptin expression and play a role in body weight gain. As a result, the composition of the microbiota and the density of the microbial load can have many positive or negative effects on human health. It is crucial for the formation of a healthy microbiota to understand better the factors affecting the microbiota, the importance of which is being understood more and more, and to know the underlying mechanisms. Creating a healthy microbiota plays an active role in the prevention of many diseases, such as obesity, inflammation, and diabetes, and in improving the general health of individuals.
CR  - Becattini, S., Taur, Y., & Pamer, E. G. (2016). Antibiotic-Induced Changes in the Intestinal Microbiota and Disease. Trends in molecular medicine, 22(6), 458–478. https://doi.org/10.1016/j.molmed.2016.04.003
CR  - Cardona, F., Andrés-Lacueva, C., Tulipani, S., Tinahones, F. J., & Queipo-Ortuño, M. I. (2013). Benefits of polyphenols on gut microbiota and implications in human health. The Journal of nutritional biochemistry, 24(8), 1415–1422. https://doi.org/10.1016/j.jnutbio.2013.05.001
CR  - Chassaing, B., Compher, C., Bonhomme, B., Liu, Q., Tian, Y., Walters, W., et al.  (2022). Randomized Controlled-Feeding Study of Dietary Emulsifier Carboxymethylcellulose Reveals Detrimental Impacts on the Gut Microbiota and Metabolome. Gastroenterology, 162(3), 743–756. https://doi.org/10.1053/j.gastro.2021.11.006
CR  - Chassaing, B., Van de Wiele, T., De Bodt, J., Marzorati, M., & Gewirtz, A. T. (2017). Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation. Gut, 66(8), 1414-1427.
CR  - Chen, Y., Zhou, J., & Wang, L. (2021). Role and Mechanism of Gut Microbiota in Human Disease. Frontiers in cellular and infection microbiology, 11, 625913. https://doi.org/10.3389/fcimb.2021.625913
CR  - Chi, L., Bian, X., Gao, B., Tu, P., Lai, Y., Ru, H., & Lu, K. (2018). Effects of the artificial sweetener neotame on the gut microbiome and fecal metabolites in mice. Molecules, 23(2), 367.
CR  - Food and Drug Administration (2023). Aspartame and Other Sweeteners in Food, Erişim adresi: https://www.fda.gov/food/food-additives-petitions/aspartame-and-other-sweeteners-food (Erişim tarihi: 13.06.2023)
CR  - Jardon, K. M., Canfora, E. E., Goossens, G. H., & Blaak, E. E. (2022). Dietary macronutrients and the gut microbiome: a precision nutrition approach to improve cardiometabolic health. Gut, 71(6), 1214–1226. https://doi.org/10.1136/gutjnl-2020-323715
CR  - Jernberg, C., Löfmark, S., Edlund, C., & Jansson, J. K. (2007). Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. The ISME journal, 1(1), 56–66. https://doi.org/10.1038/ismej.2007.3
CR  - Jonsson, A. L., and Bäckhed, F. (2017). Role of gut microbiota in atherosclerosis. Nat. Rev. Cardiol. 14 (2), 79–87. doi: 10.1038/nrcardio.2016.183
CR  - Kılıç, Ü., & Altındiş, M. (2017). Antibiyotik kullanımı ve mikrobiyota. Journal of Biotechnology and Strategic Health Research, 1, 39-43.
CR  - Kim, M. H., Yun, K. E., Kim, J., Park, E., Chang, Y., Ryu, S., et al. (2020). Gut microbiota and metabolic health among overweight and obese individuals. Scientific reports, 10(1), 19417. https://doi.org/10.1038/s41598-020-76474-8
CR  - Kozarov, E. V., Dorn, B. R., Shelburne, C. E., Dunn, W. A. Jr., and Progulske-Fox, A. (2005). Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler. Thromb. Vasc. Biol. 25 (3), e17–e18. doi: 10.1161/ 01.ATV.0000155018.67835.1a
CR  - Lange, K., Buerger, M., Stallmach, A., & Bruns, T. (2016). Effects of Antibiotics on Gut Microbiota. Digestive diseases (Basel, Switzerland), 34(3), 260–268. https://doi.org/10.1159/000443360
CR  - Li, H. Y., Zhou, D. D., Gan, R. Y., Huang, S. Y., Zhao, C. N., Shang, A., et al. (2021). Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review. Nutrients, 13(9), 3211. https://doi.org/10.3390/nu13093211
CR  - Li, M., Zheng, Y., Zhao, J., Liu, M., Shu, X., Li, Q., Wang, et al. (2022). Polyphenol Mechanisms against Gastric Cancer and Their Interactions with Gut Microbiota: A Review. Current oncology (Toronto, Ont.), 29(8), 5247–5261. https://doi.org/10.3390/curroncol29080417
CR  - Li, X., Liu, L., Cao, Z., Li, W., Li, H., Lu, C., et al. (2020). Gut microbiota as an "invisible organ" that modulates the function of drugs. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 121, 109653. https://doi.org/10.1016/j.biopha.2019.109653
CR  - Liu, C., Zhan, S., Tian, Z., Li, N., Li, T., Wu, D., et al. (2022). Food Additives Associated with Gut Microbiota Alterations in Inflammatory Bowel Disease: Friends or Enemies?. Nutrients, 14(15), 3049. https://doi.org/10.3390/nu14153049
CR  - Lloyd-Price, J., Abu-Ali, G., & Huttenhower, C. (2016). The healthy human           microbiome. Genome medicine, 8(1), 51. https://doi.org/10.1186/s13073-016-0307-y
CR  - Mitra, S., Drautz-Moses, D. I., Alhede, M., Maw, M. T., Liu, Y., Purbojati, R. W., et al. (2015). In silico analyses of metagenomes from human atherosclerotic plaque samples. Microbiome 3, 38–38. doi: 10.1186/s40168-015-0100-y
CR  - Mörkl, S., Butler, M. I., Holl, A., Cryan, J. F., & Dinan, T. G. (2020). Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry. Current nutrition reports, 9(3), 171–182. https://doi.org/10.1007/s13668-020-00313-5
CR  - Mukherjee, S., Joardar, N., Sengupta, S., & Sinha Babu, S. P. (2018). Gut microbes as future therapeutics in treating inflammatory and infectious diseases: Lessons from recent findings. The Journal of nutritional biochemistry, 61, 111–128. https://doi.org/10.1016/j.jnutbio.2018.07.010
CR  - Naimi, S., Viennois, E., Gewirtz, A. T., & Chassaing, B. (2021). Direct impact of commonly used dietary emulsifiers on human gut microbiota. Microbiome, 9(1), 66. https://doi.org/10.1186/s40168-020-00996-6
CR  - Obradovic, M., Sudar-Milovanovic, E., Soskic, S., Essack, M., Arya, S., Stewart, A. J., et al. (2021). Leptin and Obesity: Role and Clinical Implication. Frontiers in endocrinology, 12, 585887. https://doi.org/10.3389/fendo.2021.585887
Özsoy, S. (2019). Polifenoller, Mikrobiyota ve Diyabet. Beslenme ve Diyet Dergisi, 47, 102-109.
CR  - Palmnäs, M. S., Cowan, T. E., Bomhof, M. R., Su, J., Reimer, R. A., Vogel, H. J., ... & Shearer, J. (2014). Low-dose aspartame consumption differentially affects gut microbiota-host metabolic interactions in the diet-induced obese rat. PloS one, 9(10), e109841.
CR  - Pascale, A., Marchesi, N., Govoni, S., Coppola, A., & Gazzaruso, C. (2019). The role of gut microbiota in obesity, diabetes mellitus, and effect of metformin: new insights into old diseases. Current opinion in pharmacology, 49, 1–5. https://doi.org/10.1016/j.coph.2019.03.011
CR  - Ramirez, J., Guarner, F., Bustos Fernandez, L., Maruy, A., Sdepanian, V. L., & Cohen, H. (2020). Antibiotics as Major Disruptors of Gut Microbiota. Frontiers in cellular and infection microbiology, 10, 572912. https://doi.org/10.3389/fcimb.2020.572912
CR  - Rinninella, E., Cintoni, M., Raoul, P., Gasbarrini, A., & Mele, M. C. (2020). Food Additives, Gut Microbiota, and Irritable Bowel Syndrome: A Hidden Track. International journal of environmental research and public health, 17(23), 8816. https://doi.org/10.3390/ijerph17238816
CR  - Ruiz, P. A., Morón, B., Becker, H. M., Lang, S., Atrott, K., Spalinger, M. R., ... & Rogler, G. (2017). Titanium dioxide nanoparticles exacerbate DSS-induced colitis: role of the NLRP3 inflammasome. Gut, 66(7), 1216-1224.
CR  - Schirmer, M., Smeekens, S. P., Vlamakis, H., Jaeger, M., Oosting, M., Franzosa, E. A., et al. (2016). Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity. Cell, 167(4), 1125–1136.e8. https://doi.org/10.1016/j.cell.2016.10.020
CR  - Sender, R., Fuchs, S., & Milo, R. (2016). Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS biology, 14(8), e1002533. https://doi.org/10.1371/journal.pbio.1002533
CR  - Singh, R. K., Chang, H. W., Yan, D., Lee, K. M., Ucmak, D., Wong, K., et al. (2017). Influence of diet on the gut microbiome and implications for human health. Journal of translational medicine, 15(1), 73. https://doi.org/10.1186/s12967-017-1175-y
CR  - Suez, J., Korem, T., Zeevi, D., Zilberman-Schapira, G., Thaiss, C. A., Maza, O., et al. (2014). Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature, 514(7521), 181–186. https://doi.org/10.1038/nature13793
CR  - Swidsinski, A., Ung, V., Sydora, B. C., Loening-Baucke, V., Doerffel, Y., Verstraelen, H., & Fedorak, R. N. (2009). Bacterial overgrowth and inflammation of small intestine after carboxymethylcellulose ingestion in genetically susceptible mice. Inflammatory bowel diseases, 15(3), 359-364.
CR  - Taşdemir, A. (2017). Probiyotikler, prebiyotikler, sinbiyotikler. Sağlık Akademisi Kastamonu, 2(1), 71-88.
CR  - Taşkırmaz, R. N., Çakıroğlu, F. P., Meseri, R., & Küçükerdönmez, Ö. (2017). Süper organ mikrobiyota ve obezite. İzmir Kâtip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, 2(1), 45-49.
CR  - Türk Gıda Kodeksi Gıda Katkı Maddeleri Yönetmeliği (2013), Erişim adresi: https://www.resmigazete.gov.tr/eskiler/2013/06/20130630-4.htm (Erişim tarihi: 03.05.2023)
CR  - Türk Gıda Kodeksi Renklendiriciler ve Tatlandırıcılar Dışındaki Gıda Katkı Maddeleri Tebliği (2008), Erişim adresi: https://www.resmigazete.gov.tr/eskiler/2008/05/20080522-7.htm (Erişim tarihi: 03.05.2023)
CR  - Valdes, A. M., Walter, J., Segal, E., & Spector, T. D. (2018). Role of the gut microbiota in nutrition and health. BMJ (Clinical research ed.), 361, k2179. https://doi.org/10.1136/bmj.k2179
CR  - Vallianou, N. G., Stratigou, T., & Tsagarakis, S. (2019). Metformin and gut microbiota: their interactions and their impact on diabetes. Hormones (Athens, Greece), 18(2), 141–144. https://doi.org/10.1007/s42000-019-00093-w
CR  - Varım, P., Vatan, M. B., & Varım, C. (2017). Kardiyovasküler hastalıklar ve mikrobiyota. Journal of Biotechnology and Strategic Health Research, 1, 141-147.S
CR  - Wang, X., Zhang, P., & Zhang, X. (2021). Probiotics Regulate Gut Microbiota: An Effective Method to Improve Immunity. Molecules (Basel, Switzerland), 26(19), 6076. https://doi.org/10.3390/molecules26196076
CR  - Wang, R., Tang, R., Li, B., Ma, X., Schnabl, B., & Tilg, H. (2021). Gut microbiome, liver immunology, and liver diseases. Cellular & molecular immunology, 18(1), 4–17. https://doi.org/10.1038/s41423-020-00592-6
CR  - Weersma, R. K., Zhernakova, A., & Fu, J. (2020). Interaction between drugs and the gut microbiome. Gut, 69(8), 1510–1519. https://doi.org/10.1136/gutjnl-2019-320204
CR  - Yan, Q., Gu, Y., Li, X., Yang, W., Jia, L., Chen, C., et al. (2017). Alterations of the Gut Microbiome in Hypertension. Front. Cell Infect. Microbiol. 7:381:381. doi: 10.3389/fcimb.2017.00381
CR  - Yang, T., Santisteban, M. M., Rodriguez, V., Li, E., Ahmari, N., Carvajal, J. M., et al. (2015). Gut dysbiosis is linked to hypertension. Hypertension (Dallas Tex. 1979) 65 (6), 1331–1340. doi: 10.1161/HYPERTENSIONAHA. 115.05315
CR  - Yao, H., Fan, C., Fan, X., Lu, Y., Wang, Y., Wang, R., et al (2020) Effects of gut microbiota on leptin expressionand body weigh tarelessened by high-fat diet in mice. British Journal of Nutrition. 124(4):396-406.
CR  - Zhang, Q., & Hu, N. (2020). Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus. Diabetes, metabolic syndrome and obesity: targets and therapy, 13, 5003–5014. https://doi.org/10.2147/DMSO.S286430
CR  - Zhao, Y., & Jiang, Q. (2021). Roles of the Polyphenol-Gut Microbiota Interaction in Alleviating Colitis and Preventing Colitis-Associated Colorectal Cancer. Advances in nutrition (Bethesda, Md.), 12(2), 546–565. https://doi.org/10.1093/advances/nmaa104
UR  - https://doi.org/10.59778/sbfdergisi.1337716
L1  - https://dergipark.org.tr/tr/download/article-file/3308207
ER  -